Oncolytics lung cancer drug shrinks tumors in 95 percent patients Reuters India (Reuters) - Oncolytics Biotech Inc said a mid-stage trial of its experimental lung cancer drug showed that 95 percent of the patients experienced a reduction in the size of their tumors, sending its stock up as much as 38 percent. Shares of the company ... |
